ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

Missouri, Michigan Program As For Comprehensive Review

September 23, 1977

IVAX And It’s Portfolio

December 22, 1994

NIH Clinical Trials Committee Adopts Recommendations For Safety Monitoring

June 22, 1979

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008

Guest Editorial By Gregory Reaman: Memories Of A Merger Past

July 15, 2011

Coooperative Groops Announce Two Sets of Mergers: NSABP, RTOG Form Alliance; CALGB, NCCTG & ACOSOG Seek to Become Single Group

March 11, 2011